Cleared Traditional

K162407 - L300 Go System

K162407 is an FDA 510(k) clearance for L300 Go System, manufactured by Bioness, Inc.. The device is a Class 2 Neurology device with product code GZI cleared through the Traditional 510(k) pathway after a 151-day FDA review.

K162407 · Bioness, Inc. · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2017
Decision
151d
Days
Class 2
Risk

K162407 is an FDA 510(k) clearance for the L300 Go System. Classified as Stimulator, Neuromuscular, External Functional (product code GZI), Class II - Special Controls.

Submitted by Bioness, Inc. (Valencia, US). The FDA issued a Cleared decision on January 27, 2017 after a review of 151 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5810 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Bioness, Inc. devices

FDA 510(k) Submission Details - K162407

510(k) Number K162407 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2016
Decision Date January 27, 2017
Days to Decision 151 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
2d slower than avg
Panel avg: 149d · This submission: 151d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZI Device Classification - Class 2, Special Controls

Product Code GZI Stimulator, Neuromuscular, External Functional
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5810
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZI Stimulator, Neuromuscular, External Functional

All 55
Devices cleared under the same product code (GZI) and FDA review panel - the closest regulatory comparables to K162407.
RT300 FES cycle ergometer
K162470 · Restorative Therapies, Inc. · Jul 2017
MyoCycle Home, MyoCycle Pro
K170132 · Myolyn, LLC · Apr 2017
RehaStim 2
K162683 · Hasomed GmbH · Feb 2017
ReGrasp
K153163 · Rehabtronics, Inc. · Apr 2016
MYGAIT STIMULATION SYSTEM
K141812 · Otto Bock Healthcare Products GmbH · Apr 2015
WALKAIDE SYSTEM
K140886 · Innovative Neurotronics, Inc. · Aug 2014